VEPPANU

Arvinas Operations added U.S. Patent 11,597,720 to the Orange Book for Veppanu (vepdegestrant) NDA 219835.

VEPPANU (vepdegestrant) by Arvinas Operations received FDA approval under application 219835, supplement 002.

Arvinas Operations obtained New Chemical Entity exclusivity for Veppanu (vepdegestrant) under NDA 219835, providing five years of regulatory exclusivity from approval.

Arvinas Operations' VEPPANU (vepdegestrant) received FDA approval under NDA 219835.

Arvinas Operations added U.S. Patent 10,899,742 to the Orange Book for Veppanu (vepdegestrant), NDA 219835.

Arvinas Operations added U.S. Patent 10,899,742 to the Orange Book for Veppanu (vepdegestrant) NDA 219835.

Arvinas Operations added U.S. Patent 11,597,720 to the Orange Book for Veppanu (vepdegestrant) NDA 219835.

Arvinas Operations added U.S. Patent 10,647,698 to the Orange Book for Veppanu (vepdegestrant) NDA 219835.

Arvinas Operations added US Patent 10,647,698 to the Orange Book listing for Veppanu (vepdegestrant), NDA 219835.